AV8 Ventures
VC Fund
Palo Alto, United States
AV8 Ventures is a VC fund in Palo Alto focused on Health Care and Information Technology. They bring decades of experience with a hands-on approach to working closely with start-ups. Their investment and support team leverages deep technical, entrepreneurial and venture experience to help their companies succeed. Their network includes some of the brightest minds in health, machine learning, enterprise technology, mobility, robotics,hard sciences and biology.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 29%
- Fund size:
- $180M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries AV8 Ventures invests in
Stages AV8 Ventures invests in
Countries AV8 Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $2.8M–$13M
- Series A
- $7.5M–$55M
- Series B
- $13M–$71M
Investment Focus
Industry
- Health Care 10 (14%)
- Information Technology 10 (14%)
- Artificial Intelligence 8 (11%)
- Medical 7 (10%)
- Software 7 (10%)
Stage
- Seed 25 (36%)
- Series A 18 (26%)
- Series B 10 (14%)
- Venture - Series Unknown 4 (6%)
- Funding Round 2 (3%)
Country
- United States 28 (40%)
- United Kingdom 4 (6%)
- Canada 3 (4%)
- India 2 (3%)
- France 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Aaron Yang
Sr. Associate
|
Sr. Associate | Total investments: 0 | Find email | |
Brett Battles
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
George Ugras
Managing Director & Founder
|
Managing Director & Founder | Total investments: 2 | Find email | |
Ruchita Sinha
General Partner
|
General Partner | Total investments: 5 | Find email | |
Shawn Kung
Venture Partner
|
Venture Partner | Total investments: 2 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Shennon Biotechnologies analyzes and manipulates a massive number of cells on the single-cell level to develop more effective treatments for human diseases. It functionally profiles millions of immune cells to find the best targets for cancer immunotherapy. | $12M / Venture - Series Unknown / Sep 14, 2026 | ||
| Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems. | $55M / Series A / Jan 20, 2026 | ||
| Crogl investigates thousands of alerts per day following your organization's workflows by leveraging your existing security tools and data. Every action is fully documented and auditable, ensuring transparency and compliance. Whether deployed on-premises in mission-critical environments or in your cloud infrastructure, Crogl operates withcomplete privacy. | $25M / Series A / Mar 06, 2025 | ||
| Crogl investigates thousands of alerts per day following your organization's workflows by leveraging your existing security tools and data. Every action is fully documented and auditable, ensuring transparency and compliance. Whether deployed on-premises in mission-critical environments or in your cloud infrastructure, Crogl operates withcomplete privacy. | $5M / Seed / Mar 06, 2025 | ||
| Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico. | $13M / Series B / Jan 16, 2025 | ||
| AllIn Bio specializes in an immunology service intended to transform the treatment of chronic inflammatory diseases. | Seed / Jan 01, 2025 | ||
| DataGalaxy is an innovative startup, specialized in collaborative data governance. DataGalaxy offers the first agile data mapping platform, which allows teams to share a common knowledge of company data to stay focused on the essentials: creating value with data. | $7.5M / Jul 01, 2024 | ||
| Hydrolix is an early-stage startup with an ambition to change the economics of high density data. The company develops a query service technology intended to process petabyte-scale time series data.Hydrolix's cloud-based query service utilizes proprietary compression and indexing technology, allowing customers to process sub-secondinteractive queries at a fraction of the cost of other existing services. | $35M / Series B / May 22, 2024 | ||
| CoverTree offers a digital insurance solution for manufactured home residents. The company's primary goal is to bring digital distribution, automated underwriting, and data-driven pricing to specialty personal lines of insurance. CoverTree’s manufactured home product is available in Arizona, Indiana, Michigan, New Mexico, Ohio, Illinois, andTennessee.The company is headquartered in Detroit, Michigan. | $13M / Series A / May 09, 2024 | ||
| Okareo develops tools for evaluating and monitoring AI systems such as language models, agents, and retrieval-augmented generation pipelines. The platform supports automated testing, benchmarking, error analysis, regression tracking, and synthetic data generation, helping teams compare model versions, assess prompt and agent behavior, and maintainconsistent quality as systems evolve. | $4.4M / Seed / May 01, 2024 | ||
| See all 70 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does AV8 Ventures invest in?
AV8 Ventures invests primarily in Health Care, Information Technology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is AV8 Ventures's check size?
AV8 Ventures typically joins rounds of $2.8M–$13M at Seed, $7.5M–$55M at Series A and $13M–$71M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds AV8 Ventures participates in.
How do I contact AV8 Ventures?
Public channels for AV8 Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at AV8 Ventures?
The team at AV8 Ventures includes Aaron Yang (Sr. Associate), Brett Battles (Venture Partner) and George Ugras (Managing Director & Founder), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
